Dr. M. G. Finn's group in The Scripps Research Institute engages in a wide variety of collaborative interactions within Scripps and with scientists around the world.

At the core of Dr. Finn's efforts is an appreciation for the mechanisms of chemical reactivity and the desire to place efficient bond-making at the service of chemistry, biology, and materials science.

Viruses as Molecular Building Blocks

Inspired and educated by Prof. John E. Johnson and coworkers at Scripps, Dr. Finn’s group is using icosahedral plant and insect viruses as reagent-scale participants in organic and organometallic reactions. This is a fast-developing field which impacts biology, chemical catalysis, nanotechnology, and materials science. Dr. Finn’s group has focused initially on cowpea mosaic virus (CPMV), a relatively simple icosahedral particle composed of 60 identical copies of a 65-kD coat protein around a single-stranded RNA genome. From chemical perspective, the most important qualities of CPMV are that it is very stable (pH 3.5-10, up to 50 degrees C, up to 50% organic co-solvent), can be generated in gram quantities, is crystallographically characterized to high resolution, and can be genetically changed by standard mutagenesis techniques. CPMV is therefore a highly accessible protein scaffold.

It is the size and polyvalency of such scaffolds that make them so useful: virus particles occupy the physical and conceptual space between chemistry and biology. They are many times larger than almost all products of synthetic chemistry, and many times smaller than most cells. But they are not so large as to be out of reach of chemical techniques, and large enough to present surfaces of biologically relevant size to cells and tissues. Combining organic chemistry and molecular biology to create and modify these particles is powerful.

At the present time, research is ongoing in the following areas:

Chemical Fundamentals.   New methods of chemical derivatization of proteins and virions; enhancing particle stability; learning the chemistry of new viruses particles.

Polyvalent Presentation to Biology.  Attachment of biologically active compounds, from small molecules to proteins, to virus scaffolds and exploration of their impact on biological systems. Work includes the display of carbohydrate, peptide, and drug molecules, and characterizing interactions with cellular receptors and tissues.

Catalysis.  Arraying of organometallic and organic catalytic engines on virus particles, and use of the tunable virus structure to influence catalyst activity. Such systems are easy to separate from reaction products and provide high local concentrations of catalysts in otherwise dilute solutions, which creates opportunities for interesting reaction cascades and therapeutic applications.

Nanoparticle Assemblies and Materials Science.  Programmed self-assembly of virus particles in two and three dimensions; hybrid materials incorporating virus building blocks, metal and ceramic nanoparticles, and organic polymers. The goals here encompass aspects of nanotechnology, sensors, and molecular actuators.

Selection and Evolution.  Creation of virus libraries and selection for function, retaining the property of high expression yields.

Organic Chemistry

"Click Chemistry". As defined by K.B. Sharpless, "click" chemistry involves the use of only the most reliable, general, high-yielding, and byproduct-free organic reactions for the construction of compounds with desired function. Its central hypothesis is that most, if not all, chemical functions can be attained by many different compounds among the nearly limitless possibilities of three-dimensional structural space. If you restrict yourself as much as possible to using only the best reactions, more diversity will be accessible, since your reactions work with a wider variety of pieces. One stands a better chance, therefore, of finding functional molecules this way, although they will not look like the compounds made by nature for the same purpose.

To appreciate the possibilities, synthetic chemists might ask themselves “what if every bond connection worked flawlessly, regardless of the structure of the connecting pieces?” Non-practitioners of the synthetic art, might wonder what would be possible if molecules of any desired shape or pattern of functional group display were available without much trouble. Dr. Finn’s group is not yet close to such ideals, but the concept is powerful and enabling.

Click reactions tend to involve high-energy (“spring-loaded”) reagents with well-defined reaction coordinates, giving rise to selective bond-forming events of wide scope. Examples include the nucleophilic trapping of strained-ring electrophiles (epoxide, aziridines, aziridinium ions, episulfonium ions), certain forms of carbonyl reactivity (aldehydes + hydrazines or hydroxylamines, for example), and several types of cycloaddition reactions. The azide-alkyne 1,3-dipolar cycloaddition has emerged as the most important. Dr. Finn group’s collaborative efforts using click chemistry include three projects.

Synthesis of Drug Candidates: in situ Formation of Enzyme Inhibitors (with Profs. K. Barry Sharpless, Valery Fokin, and Hartmuth Kolb of TSRI). The 1,2,3-triazole-forming azide-alkyne cycloaddition involves a pair of groups which are uniquely reactive with each other and unreactive with nearly all other structures in biology. It thus provides a way to stitch pieces together in the presence of biomolecules and even living organisms. Dr. Finn’s group has exploited this capability by asking an enzyme to assemble its own inhibitor in situ. Acetylcholinesterase has two known small-molecule binding sites at either end of a narrow gorge. When presented with pairs of binding pieces to which azide and alkyne were attached, one combination was assembled into a bivalent triazole in the enzyme binding pocket.

This compound, shown in the structure on the left (thanks to Dr. Flavio Grynszpan for the image), is a femtomolar inhibitor of the enzyme, binding more strongly than the best previously known noncovalent inhibitors (including snake venom toxin) by two orders of magnitude. More exciting still has been follow-up x-ray structural studies which show that such strong binding is accompanied by an unprecedented change in enzyme structure -- a true example of the induced fit model of enzyme inhibition.

These findings demonstrate that the "kinetic capture" of such a compound by azide-alkyne cycloaddition gave rise to a structure that could not have been anticipated by even the most sophisticated molecular modeling, since all such modeling is based on known structural forms of the enzyme.

Dr. Finn's group is currently using these techniques in collaboration with the laboratory of Prof. Palmer Taylor at UCSD in a search for selective small-molecule agonists and antagonists of acetylcholine binding proteins. Dr. Finn’s group is also engaged in a collaborative search for inhibitors to HIV protease and its many clinically important mutants. In these cases, the protein targets are multi-subunit entities with bivalent or multivalent binding sites created at protein-protein interfaces. Such systems - ubiquitous in biochemistry - are natural targets for the click chemistry approach.

Materials Synthesis with "Click Chemistry"

The branch of chemistry most heavily dependent on reactions which meet the click chemistry standard is polymer synthesis. Indeed, the reliability of polymerization reactions and the rich functions of the products were among the original inspirations for the click chemistry concept. The identification of each new click reaction immediately enables the synthesis of novel materials.

Prof. Valery Fokin and coworkers of TSRI discovered in 2002 that Cu(I) accelerates the azide-alkyne cycloaddition to a remarkable degree in aqueous solutions, establishing the process as the cream of the click chemistry crop. Dr. Finn’s group is employing it in dendrimer chemistry and template polymerization and intend to significantly expand this part of Dr. Finn group’s research. As shown on the next page, the production of adhesives provides the best example thus far of a functional material made with this process.

Since copper metal provides Cu(I) ions which catalyze the reaction, and the product triazoles are known to bind well to metallic surfaces, mixtures of polyvalent azides and alkynes comprise adhesives which glue copper to itself or other metals in a cycloaddition curing process. The resulting materials are much stronger than commercial metal adhesives.

Tunable Electrophiles. In addition to their obvious importance to synthetic chemistry, electrophiles stable to water but reactive with protein side chains are highly useful as probes and potential covalent inhibitors of enzymatic function. Dr. Finn's group currently focuses on two families of electrophiles with interesting reactivity.

Mass Spectroscopy

Dr. Finn's group has two main projects in the development of new mass spectrometric techniques: (a) analysis of chiral compounds, and (b) porous silicon based desorption/ionization. Each bears its own clever acronym.

Mass Spectrometry Enantiomeric Excess Determination (MSEED). Combinatorial approaches to catalyst discovery are centrally dependent on efficient methods for determining catalytic activity and enantioselectivity. Responding to this challenge, Dr. Finn’s group has developed kinetic resolution-based methods for the rapid determination of enantiomeric excess of many types of organic compounds using mass spectrometry.

                                                      
As shown in general form here, the technique employs enantiopure reagents (R-Y, S-Y) of different mass but designed to react as enantiomers with the chiral analyte of interest (R-X, S-X). The presence of even a slight degree of kinetic resolution (k1 not equal to k2) allows the determination of the ratio of analyte enantiomers to ±10% ee by measurement of the ratio of product masses from the probe reaction. For calibration, a sample of the racemic analyte and a sample of known enantiomeric excess are required.

The method is suited to initial screening of candidate catalysts, since neither chiral chromatography nor purification of reaction mixtures is required. Catalyst substrates do not need to be tagged with chromophores or other labels. Different substrates can be processed at the same time, since no analytical optimization is required and only the masses of interest are important - all other peaks in the mass spectrum can be ignored. Dr. Finn’s group continues to develop these techniques, which are currently being extended to chiral epoxides, ketones, aldehydes, olefins, alkynes, and azides.

Desorption/Ionization on Silicon (DIOS). In 1999, Prof. Gary Siuzdak and Dr. Jillian Buriak of TSRI reported that the use of porous silicon (pSi) instead of a gold plate allowed the analysis of small molecules using MALDI (matrix-assisted laser desorption/ionization) instrumentation.

Here you see a photopatterned DIOS pSi wafer and a scanning electron micrograph (thanks to Mark Englehard of Batelle Laboratories) of the porous layer of such materials.   

The matrix-free DIOS-MS technique has been studied and refined since that time by a collaboration involving the TSRI Mass Spectrometry Laboratory (Prof. G. Siuzdak), Dr. Finn group’s group, and the lab of Prof. John Crowell at UCSD. Important developments include the following:

• Extremely rapid data collection (3 seconds per sample).
• Sensitivity up to the high attomolar level, comparable to the best    nano-electrospray techniques.
• Excellent quantitation using electrospray deposition on the silicon plate, allowing quantitative and relative reaction kinetics to be measured.
• Better tolerance of complex mixtures and salts than electrospray ionization.
• Covalent modifications of the pSi surface to enhance stability and allow the technique to be optimized for particular types of compounds.
• Covalent linkages which are efficiently broken in the DIOS laser pulse, allowing for rapid, positionally-encoded screening of compounds for reactivity toward catalysts or reagents in solution.

Current projects focus on more refined tailoring of the pSi surface, improving DIOS performance, elucidating the mechanism of the DIOS phenomenon, and applying the technique to a variety of targets in catalysis, biology, and medicine.

Organometallic Catalysis

With the mass spectrometry techniques described above, Dr. Finn’s group identifies and optimize both early (Ti, Zr, etc.) and late (Rh, Ni) transition metal catalysts for a variety of transformations. This effort is driven by considerations of synthetic organic chemistry, in terms of both targets and methods of ligand synthesis, and by themes of catalytic mechanism.  In one example, a panel of chiral phosphite P,N ligands was constructed for the Rh-catalyzed hydrosilylation of ketones. With mass spectrometry screening, one ligand was identified as optimal for four substrates, but two other ketones required slightly different ligand. Mechanistic investigation revealed the active catalysts to be 1:1 Rh:ligand complexes in which the sp3-nitrogen centers, unusual for Rh(I) chemistry, were crucially important.

An example of a project of current interest is an effort to control the aggregation state of early transition metal chiral Lewis acid catalysts by making and using them on solid supports. 

In analogous fashion to the use of viral surfaces described above, Dr. Finn’s group believes that the nature of the solid support will have a profound influence on the selectivity and activity of many catalysts which engage in reversible aggregation.

The chemistry of metallacarborane complexes is an important sub-theme in this area. As a result of Dr. Finn group’s longstanding collaboration with the group of Prof. Russell Grimes at the University of Virginia, Dr. Finn’s group has developed an appreciation for the unique electronic and steric properties of the R2C2B3 ligand and will be re-injecting its versatile chemistry into the program. The C2B3 analogue to cyclopentadiene is far more electron-rich and is able to coordinate metals on both of its faces, giving rise to highly tunable and very stable complexes. As a platform for constructing ligands, including chiral planar-chiral derivatives, Dr. Finn’s group believes it offers superior capabilities.

Publications:

"Unnatural Amino Acid Incorporation into Virus-Like Particles" Strable, E.; Prasuhn, D.E., Jr.; Udit, A.K.; Brown, S.; Link, A.J.; Ngo, J.T.; Lander, G.; Quispe, J.; Potter, C.S.; Carragher, B.; Tirrell, D.A.; Finn, M.G. Bioconjugate Chem. 2008, 19, 866-875.     
"On-Virus Construction of Polyvalent Glycan Ligands for Cell-Surface Receptors" Kaltgrad, E.; O'Reilly, M.K.; Liao, L.; Han, S.; Paulson, J.; Finn, M.G. J. Am. Chem. Soc. 2008, 130, 4578-4579.    
"Electrochemically Protected Copper(I)-Catalyzed Azide-Alkyne Cycloaddition" Hong, V.; Udit, A.K.; Evans, R.A.; Finn, M.G. ChemBioChem 2008, in press.    
        "Cowpea Mosaic Virus Capsid, a Promising Carrier for the Development of Carbohydrate Based Anti-tumor Vaccines" Miermont, A.; Barnhill, H.; Strable, E.; Lu, X.; Wall, K.A.; Wang, Q.; Finn, M.G.; Huang, X. Chem. Eur. J. 2008 14, 4939-4947    
      “Plasma Clearance of Bacteriophage Q-beta Particles as a Function of Surface Charge” Prasuhn, D.E., Jr.; Singh, P.; Strable, E.; Brown, S.; Manchester, M.; Finn, M.G. J. Am. Chem. Soc. 2008, 130, 1328-1334.    
      “Anti-Carbohydrate Antibodies Elicited by Polyvalent Display on a Viral Scaffold” Kaltgrad, E.; Sen Gupta, S.; Punna, S.; Huang, C.-Y.; Chang, A.; Wong, C.-H. Finn, M.G.; Blixt, O. ChemBioChem 2007, 8, 1455-1462.    
      “Folic Acid-Mediated Targeting of Cowpea Mosaic Virus Particles to Tumor Cells” Destito, G.; Yeh, R.; Rae, C.S.; Finn, M.G.; Manchester, M. Chem. Biol. 2007 14, 1152-1162.    
       "Viral MRI Contrast Agents: Coordination of Gd by Native Virions and Attachment of Gd Complexes by Azide-Alkyne Cycloaddition" Prasuhn Jr., D.E.; Yeh, R.M.; Obenaus, A.; Manchester, M.; Finn, M.G.  Chem. Commun. 2007,1269-1271    
           
        "Bio-distribution, Toxicity, and Pathology of Cowpea Mosaic Virus Nanoparticles in vivo" Singh, P.; Prasuhn, D.; Yeh, R.M.; Destito, G.; Rae, C.; Osborn, K.; Finn, M.G.; Manchester, M.J. Controlled Rel.  2007, 120,41-50.